http://www.pharm.emory.edu/dingledine/ WebThe Imagine, Innovate, and Impact Awards – or I3 – were launched in 2024 to encourage connections between disciplines and accelerate the pace of discovery. A total of $595,000 was awarded during the first round to fund projects in both research and education. On February 1, 2024, a new category of I3 awards was launched - the Venture Research …
Start-up Founder From The Trenches - Emory Technology Transfer …
http://shared.web.emory.edu/emory/news/releases/2010/10/institute-of-medicine-elects-ray-dingledine.html http://www.pharm.emory.edu/dingledine/people/lab-photos.html the hello brand
Dr. Raymond J. Dingledine to Launch Center for …
WebJan 16, 2024 · Holly Korschun. (404) 727-3990. [email protected]. The American … WebFeb 9, 2012 · “EP2 is involved in many disease processes where inflammation is showing up in the nervous system, such as epilepsy, stroke and neurodegenerative diseases,” says senior author Ray Dingledine, PhD, chairman of Emory's Department of Pharmacology. “Anywhere that inflammation is playing a role via EP2, this class of compounds could be … WebI completed my post-doctoral studies at Emory University in the Department of Pharmacology, with Dr. Raymond Dingledine. We worked to identify the agonist binding site of the N-methyl-D-aspartate receptor by constructing receptor chimeras. Chimeras were characterized pharmacologically through transient expression studies in Xenopus laevis … the hell movie